POLICY CASE STUDIES (BRIEF RESEARCH)
Patient journey pain points in spondyloarthritis and psoriasis: The case of Greece
 
More details
Hide details
1
Medical School, University of Crete, Greece
2
Department of Healthcare, Faculty of Public Health, University of Vlora, Vlora, Albania
CORRESPONDING AUTHOR
Enkeleint Aggelos Mechili   

Medical School, University of Crete, Heraklion 715 00, Greece
Publication date: 2019-11-12
Submission date: 2019-07-23
Final revision date: 2019-09-20
Acceptance date: 2019-10-25
 
Popul. Med. 2019;1(November):4
KEYWORDS
TOPICS
ABSTRACT
For the diseases spondyloarthritis (SpA) and psoriasis, the patient’s journey commences when the first symptoms present themselves. However, many patients ignore the initial symptoms, until the moment they become unbearable. Additionally, due to GPs/family physicians and primary healthcare providers’ lack of knowledge, both SpA and psoriasis remain underdiagnosed, and patients need to undertake multiple visits and health examinations to get correctly diagnosed. With regard to appropriate treatment, a combination of pharmacotherapy, counselling and education is useful to improve the patient’s quality of life, with healthcare professionals ensuring the patient’s adherence to the therapy. In Greece, the lack of health protocols and health technology assessment procedures create a burden in the screening, diagnosis and treatment of patients with SpA and psoriasis. Based on the aforementioned, the existence of a comprehensive, patient-centred and integrated healthcare system is of crucial importance so that patients with chronic conditions can have quality healthcare, better prognosis and reduced cost of care.
CONFLICTS OF INTEREST
The authors have completed and submitted the ICMJE Form for Disclosure of Potential Conflicts of Interest and none was reported.
FUNDING
There was no source of funding for this research.
PROVENANCE AND PEER REVIEW
Not commissioned; externally peer reviewed.
 
REFERENCES (24)
1.
Egeberg A, Andersen YMF, Thyssen JP. Prevalence and characteristics of psoriasis in Denmark: findings from the Danish skin cohort. BMJ Open. 2019;9(3):e028116. doi:10.1136/bmjopen-2018-028116
 
2.
Duba AS, Mathew SD. The Seronegative Spondyloarthropathies. Prim Care Clin Off Pract. 2018;45(2):271-287. doi:10.1016/j.pop.2018.02.005
 
3.
Ronneberger M, Schett G. Pathophysiology of Spondyloarthritis. Curr Rheumatol Rep. 2011;13(5):416-420. doi:10.1007/s11926-011-0202-x
 
4.
Bakland G, Alsing R, Singh K, Nossent JC. Assessment of SpondyloArthritis International Society criteria for axial spondyloarthritis in chronic back pain patients with a high prevalence of HLA-B27. Arthritis Care Res (Hoboken). 2013;65(3):448-453. doi:10.1002/acr.21804
 
5.
Trontzas P, Andrianakos A, Miyakis S, et al. Seronegative spondyloarthropathies in Greece: a population-based study of prevalence, clinical pattern, and management. The ESORDIG study. Clin Rheumatol. 2005;24(6):583-539. doi:10.1007/s10067-005-1106-9
 
6.
Albaghdadi A. Current and Under Development Treatment Modalities of Psoriasis: A Review. Endocrine, Metab Immune Disord - Drug Targets. 2017;17(3):189-199. doi:10.2174/1871530317666170804153751
 
7.
Sen R, Hurley JA. Seronegative Spondyloarthropathy. Treasure Island, FL: StatPearls Publishing; 2019. doi:10.1093/med/9780199568741.003.0268
 
8.
World Health Organization. Global report on Psoriasis. Geneva, Switzerland: World Health Organization; 2016. https://apps.who.int/iris/hand.... Accessed July 23, 2019.
 
9.
Saad CGS, Gonçalves CR, Sampaio-Barros PD. Seronegative Arthritis in Latin America: A Current Review. Curr Rheumatol Rep. 2014;16(9):438. doi:10.1007/s11926-014-0438-3
 
10.
Rigopoulos D, Gregoriou S, Katrinaki A, et al. Characteristics of psoriasis in Greece: an epidemiological study of a population in a sunny Mediterranean climate. Eur J Dermatol. 2010;20(2):189-195. doi:10.1684/ejd.2010.0869
 
11.
Papadavid E, Katsimbri P, Kapniari I, et al. Prevalence of psoriatic arthritis and its correlates among patients with psoriasis in Greece: results from a large retrospective study. J Eur Acad Dermatology Venereol. 2016;30(10):1749-1752. doi:10.1111/jdv.13700
 
12.
Sihgh JA, Strand V. Spondyloarthritis Is Associated with Poor Function and Physical Health-Related Quality of Life. J Rheumatol. 2009;36(5):1012-1020. doi:10.3899/jrheum.081015
 
13.
Haroon NN, Paterson JM, Li P, Inman RD, Haroon N. Patients With Ankylosing Spondylitis Have Increased Cardiovascular and Cerebrovascular Mortality. Ann Intern Med. 2015;163(6):409. doi:10.7326/m14-2470
 
14.
Rudwaleit M, Haibel H, Baraliakos X, et al. The early disease stage in axial spondylarthritis: Results from the german spondyloarthritis inception cohort. Arthritis Rheum. 2009;60(3):717-727. doi:10.1002/art.24483
 
15.
Economou C, Kaitelidou D, Karanikolos M, Maresso A. Greece: Health System Review. Health Syst Transit. 2017;19(5):1-166.
 
16.
Ko S, Chi C, Yeh M, Wang S, Tsai Y HM. Lifestyle changes for treating psoriasis. Cochrane Database Syst Rev. 2019;7:CD011972. doi:10.1002/14651858.CD011972.pub2
 
17.
Jois RN, Macgregor AJ, Gaffney K. Recognition of inflammatory back pain and ankylosing spondylitis in primary care. Rheumatology. 2008;47(9):1364-1366. doi:10.1093/rheumatology/ken224
 
18.
National Institute for Health and Care Excellence. Spondyloarthritis overview - NICE Pathways. 2019. https://pathways.nice.org.uk/p.... Accessed July 23, 2019.
 
19.
Bhosle MJ, Kulkarni A, Feldman SR, Balkrishnan R. Quality of life in patients with psoriasis. Health Qual Life Outcomes. 2006;4:35. PMID:16756666.
 
20.
Percival J, McGregor C. An Evaluation of Understandability of Patient Journey Models in Mental Health. JMIR Hum factors. 2016;3(2):e20. doi:10.2196/humanfactors.5640
 
21.
Health Equality Europe. Understanding Health Technology Assessment (HTA). 2008. https://htai.org/wp-content/up.... Accessed July 23, 2019.
 
22.
Mumtaz A, FitzGerald O. Application of the GRAPPA Psoriatic Arthritis Treatment Recommendations in Clinical Practice. Curr Rheumatol Rep. 2010;12(4):264-271. doi:10.1007/s11926-010-0109-y
 
23.
López-Estebaranz JL, de la Cueva-Dobao P, de la Torre Fraga C, et al. Manejo de la psoriasis moderada-grave en condiciones de práctica habitual en el ámbito hospitalario español. Actas Dermosifiliogr. 2018;109(7):631-642. doi:10.1016/j.ad.2018.02.015
 
24.
Atreja A, Bellam N, Levy SR. Strategies to enhance patient adherence: making it simple. MedGenMed. 2005;7(1):4. PMID:16369309.
 
ISSN:2654-1459